PBMs

Opinion: Top 2 takeaways from UBS Global Healthcare ConferenceThe conference raised important points about unregulated growth opportunities and new pharmacy arena players.
Four ways PBMs must change to thrive in the future
Four ways PBMs must change to thrive in the futureThe days of the traditional, channel-focused and largely enshrouded PBM business model have come and gone. Here’s what’s next.
Can Amazon change the pharmacy landscape?Industry experts analyze issues of mail delivery and transparency in the prescription drug market.
Why This PBM Comparison Is a Bit of a WhopperAre pharmacies really comparable to fast-food outlets?
Fourteen things Trump needs to know about opioidsAs President Trump promises fight the opioid epidemic, here are 14 things experts want him to know.
Reader Response
Drug Spending Slows for Major Pharmacy Benefit Managers
Partnership aims to make insulin more affordableCVS, Novo Nordisk launch a prescription savings program to help patients afford essential medications.
Pharmacists to Descend on Washington
Pharmacists to Descend on WashingtonDIR fees and health-care reform will lead pharmacists’ legislative concerns.
DIRs: PBMs Pay Less Each Year While Prices Go UpPBMs have a business model where they pay less even while prices go up.